Vimarsana
Biggest News Aggregation in the World

Chronic Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chronic Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chronic Phase Today - Breaking & Trending Today

CNN The Whole Story With Anderson Cooper September 8, 2024 - Vimarsana News

CNN The Whole Story With Anderson Cooper September 8, 2024

Welcome to the whole story. I'm anderson cooper, after vice president kamala harris became the democratic nominee, she launched an aggressive campaign to reintroduce herself to the country but with the election looming, many remain undecided and are looking at where harris stands on the issues that matter to them before casting their ballots. Over the next hour, cnn's audie cornish looks at harris's record and her promises on five key issues in this election reproductive rights immigration, foreign policy, the state of democracy, and one that most american side is they're our priority. The eco...

Novartis Scemblix® shows superior major molecular response - Vimarsana News

Novartis Scemblix® shows superior major molecular response

MEDIA & INVESTOR RELEASE Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard-of-care TKIs in Phase III trial for...

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting - Vimarsana News

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting

Updated iptacopan data confirm hemolysis control in paroxysmal nocturnal hemoglobinuria patients from Phase III APPLY-PNH and APPOINT-PNH studies Head-to-head data from Phase III... | May 11, 2023

Novartis Pharma AG: Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting - Vimarsana News

Novartis Pharma AG: Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting

Updated iptacopan data confirm hemolysis control in paroxysmal nocturnal hemoglobinuria (PNH) patients from Phase III APPLY-PNH and APPOINT-PNH studies Head-to-head data from Phase III ASCEMBL trial

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia | Small Molecules - Vimarsana News

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia | Small Molecules

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia